Table 3 Acute toxicity of concurrent cisplatin with hypofractionation (HYP-UK) for locally advanced head and neck cancer. According to the Common Terminology Criteria for Adverse Events Version 3.0
Acute adverse event | Grade 1/2 | Grade 3 | Grade 4 |
|---|---|---|---|
n (%) | n (%) | n (%) | |
Hematological | |||
Anemia | 7 (35) | 0 | 0 |
Lymphopenia | 7 (35) | 3 (15) | 1 (5) |
Thrombocytopenia | 1 (5) | 0 | 0 |
Neutropenia | 5 (25) | 1 (5) | 0 |
Febrile Neutropenia | 0 | 1(5) | 0 |
Non-Hematological | |||
Radiodermatitis | 19 (95) | 6 (30) | 0 |
Mucositis | 15 (75) | 8 (40) | 0 |
Increased serum creatinine | 1 (5) | 0 | 0 |